Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: celecoxib|DRUG: Celecoxib
Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)